The Federal Trade Commission in October brought its  long-anticipated  lawsuit against the nation’s three biggest ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

In 2015, researchers discovered that some species, like Conus geographus, make venoms that contain con-insulin, a toxin that ...

The combination of intranasal insulin (INI) and the sodium-glucose cotransporter ... Metabolic and vascular disorders are ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp increase seems to be simple: corporate greed. Recently ...

Allie Goecke-Butler didn't choose to get diabetes at 24 and become insulin dependent, but yet she says, "staying alive is becoming more and more expensive." ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...